Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The objective of this phase III, placebo-controlled platform study is to investigate the efficacy of drugs for patients with ALS (Amyotrophic lateral sclerosis).
Epistemonikos ID: 0c6ed42b7364cafcebec62790aa0d65ff29b64ab
First added on: May 15, 2024